# Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease

> **NCT00758784** · PHASE2 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 38 (actual)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** bromfenac ophthalmic solution 0.06%

## Key facts

- **NCT ID:** NCT00758784
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-13
- **Primary completion:** 2009-01-14
- **Final completion:** 2009-01-14
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2020-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758784, "Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00758784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*